Home / Recalls / Kroger Specialty Pharmacy, Inc. / D-0799-2018

D-0799-2018 Class II Terminated

Recalled by Kroger Specialty Pharmacy, Inc. — Vicksburg, MS

Recall Details

Product Type
Drugs
Report Date
May 16, 2018
Initiation Date
April 3, 2018
Termination Date
May 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
Unknown

Product Description

Kisqali 600 Dose 63 tablet 200 mg NDC 00078-0874-63 28 days supply

Reason for Recall

Lack of Processing Controls.

Distribution Pattern

MS, LA, AR, IL, FL

Code Information

All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018

Other recalls by Kroger Specialty Pharmacy, Inc.

  • D-0795-2018 Class II — Perjeta 420 mg/14 mL SDV Vials 50242-0145-01 21 days supply (April 3, 2018)
  • D-0772-2018 Class II — Revlimid 15 mg oral cap NDC 59572-0415-21 28 days supply (April 3, 2018)
  • D-0776-2018 Class II — Avonex 30 mcg/0.5 mL PFS Kit NDC 59627-0222-05 28 days supply (April 3, 2018)
  • D-0747-2018 Class II — Botox 100 Units Vial NDC 00023-1145-01 90 days supply. (April 3, 2018)
  • D-0746-2018 Class II — Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply; (April 3, 2018)
  • D-0784-2018 Class II — Sprycel 100 mg tablet NDC 00003-0852-22 30 days supply (April 3, 2018)
  • D-0751-2018 Class II — Orkambi 100 mg/125 mg Tablets #112 NDC 51167-0700-02 28 days supply. (April 3, 2018)
  • D-0785-2018 Class II — Cyclophosphamide 50 mg cap NDC 00054-0383-25 28 days supply (April 3, 2018)
  • D-0793-2018 Class II — Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply (April 3, 2018)
  • D-0779-2018 Class II — Xalkori 250 mg cap NDC 00069-8140-20 30 days supply (April 3, 2018)